Estrogen-associated hypercoagulability

View Premenstrual Syndrome (PMS) Slideshow Pictures

Medical Definition of Estrogen-associated hypercoagulability

Estrogen-associated hypercoagulability: Hyper-coagulable blood (a supranormal tendency for blood to clot) occurs as an occasional but serious side effect of estrogen therapy. The blood clots in this situation are dose-related; that is, they occur more frequently with higher doses of estrogen. All estrogen therapy preparations carry this risk. Cigarette smokers on estrogen therapy are at a higher risk for blood clots than nonsmokers. Therefore, patients requiring estrogen therapy are strongly encouraged not to smoke.


Quick GuidePremenstrual Syndrome (PMS): Track and Prevent Symptoms

Premenstrual Syndrome (PMS): Track and Prevent Symptoms

Subscribe to MedicineNet's Women's Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Reviewed on 6/9/2016

Health Solutions From Our Sponsors